OS and PFS
. | Median (95% CI), mo . | 1 y, % . | 2 y, % . | P . |
|---|---|---|---|---|
| OS | ||||
| Nonmyeloablative | 13.0 (7.8, 24.8) | 51 | 39 | .06 |
| Myeloablative | 5.8 (3.4, 8.6) | 38 | 29 | — |
| PFS | ||||
| Nonmyeloablative | 7.8 (6.0, 13.0) | 40 | 27 | .24 |
| Myeloablative | 4.4 (2.5, 8.4) | 36 | 25 | — |
. | Median (95% CI), mo . | 1 y, % . | 2 y, % . | P . |
|---|---|---|---|---|
| OS | ||||
| Nonmyeloablative | 13.0 (7.8, 24.8) | 51 | 39 | .06 |
| Myeloablative | 5.8 (3.4, 8.6) | 38 | 29 | — |
| PFS | ||||
| Nonmyeloablative | 7.8 (6.0, 13.0) | 40 | 27 | .24 |
| Myeloablative | 4.4 (2.5, 8.4) | 36 | 25 | — |
— indicates not applicable.